Mensali N, Joaquina S, de Montlaur C, Casey NP, Nesset TO, Myklebost O, McCormack E, Pasetto A, Gunnes MW, Gelebart P, Inderberg EM, Wälchli S (2026)
Pre-clinical validation of OSCAR-3 mRNA-based CAR T cells for targeting osteosarcomas
Cytotherapy, 28 (12), 102930 (in press)
DOI 10.1016/j.jcyt.2026.102930, PubMed 42854615

Kostas M, Munthe E, Haugsten EM, Mateus D, Sørensen V, Laerdahl JK, Szybowska P, Wiedlocha A, Lecaudey LA, Nakken S, Schink KO, Stenmark H, Wesche J (2026)
Unconventional activation of the proto-oncogene FGFR1 by extracellular phosphate via H₂O₂-mediated kinase oxidation
Cell Rep, 45 (6), 117504
DOI 10.1016/j.celrep.2026.117504, PubMed 42247296

Napolitano A, Joensuu H, Rothschild S, Evans D, Heinrich MC, Sutton TL, Mayo SC, Boye K, Falkenhorst J, Le Cesne A, Hohenberger P, Rutkowski P, van Houdt WJ, Steeghs N, Gelderblom H, Desar IME, Pantaleo MA, Nishida T, Reichardt P, Blay JY, Somaiah N, Haddad EFN, Grignani G, Baldi GG, Steigen SE, Braconi C, Nilsson B, Singh AS, Fumagalli E, Cananzi FCM et al. (2026)
Adjuvant Imatinib or Observation in Patients With Gastrointestinal Stromal Tumors With KIT Exon 9 Mutations
JAMA Oncol, 12 (4), 407-412
DOI 10.1001/jamaoncol.2026.0007, PubMed 41746633